The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen
Stock and Other Ownership Interests - Janssen

Patterns of prostate cancer management across Canadian prostate cancer treatment specialists.
 
Bobby Shayegan
No Relationships to Disclose
 
Alan I. So
Honoraria - Amgen; Astellas Pharma; Janssen
Consulting or Advisory Role - Amgen; Astellas Pharma; Janssen
Speakers' Bureau - Amgen
 
Shawn Malone
Honoraria - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Sanofi
 
Sebastien J. Hotte
Honoraria - Astellas Scientific and Medical Affairs Inc; Janssen Oncology; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Pfizer
Research Funding - Agensys; AstraZeneca; Bayer; Boehringer Ingelheim; Novartis; Oncogenex; Roche/Genentech; Sanofi
 
Antonio Finelli
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb; Roche Pharma AG
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Roche Canada; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Roche Canada; Sanofi
 
Christina M. Canil
Honoraria - Janssen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Merck; Novartis; Pfizer; Roche Canada; Sanofi
Research Funding - AstraZeneca (Inst); Janssen (Inst)
 
Huong Hew
No Relationships to Disclose
 
Laura Park-Wyllie
Employment - Janssen
 
Kim N. Chi
Honoraria - Amgen; Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Lilly/ImClone (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst); Tokai Pharmaceuticals (Inst)
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Janssen Oncology; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)